Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XED-60 in the Treatment of Dry Eye (Phase 2)
jRCT1080222777Phase 2
- Sponsor
- Lion Corporation
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in dry eye syndrome (DED) comparing XED-60 with Placebo (2 arms).
02
Drugs
XED-60
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT1080222777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222777.